Alan Packer


Alan Packer joined the Simons Foundation in 2009 as an associate director of research. He earned his undergraduate degree in biology from Brandeis University and his Ph.D. in cell biology and genetics from the Weill Cornell Graduate School of Medical Sciences in New York City. His graduate work with Rosemary Bachvarova focused on germ cell development using the mouse as a model system. With Debra Wolgemuth at the Columbia University College of Physicians and Surgeons, he carried out postdoctoral work on developmental control genes (HOX genes) and the mechanisms of their regulation in the mouse embryo. In 2000, Packer joined the editorial staff of Nature Genetics, the leading journal in the field of genetics, where he was involved in all aspects of the journal’s production. His responsibilities included overseeing peer review of submitted manuscripts, with an emphasis on the genetics of human disease, as well as commissioning reviews, writing press releases and editorials, updating the journal’s website, and preparing special issues of the journal. He served as acting editor in 2002-2003. During his tenure at Nature Genetics, he established a wide range of contacts in the genetics community through attendance at meetings and visits with scientists in their labs. Packer has also done freelance writing on a number of topics for Nature and other scientific publications.

From this contributor

Explore more from The Transmitter

Ehud Ahissar offers a new kind of dualism for neuroscience

He explains how “perceptual dualism” can account for the way we communicate via digital symbols and perceive the world via analog brain processes.

By Paul Middlebrooks
6 May 2026 | 102 min listen

Microglia in hypothalamus help kick-start puberty

In a “surprise” role, the cells regulate the neurons that produce gonadotropin-releasing hormone.

By Helena Kudiabor
6 May 2026 | 0 min watch
DNA helix.

Advances in genetic medicine took center stage at INSAR

The president of the Autism Science Foundation and parent of a child with profound autism reflects on how advances in the treatment of rare gene variants bring hope to many families.

By Alison Singer
5 May 2026 | 4 min read